Recent Updates
Recently added Catalysts
HIT Positive Sentiment Score: 85/100

Health In Tech Announces Third Quarter 2025 Financial Results Revenue reached $8.5 million, up 90% year over year; nine-month revenue totaled $25.8 million, representing 132% of full-year 2024 total revenue. Adjusted EBI

Key Takeaway: Health In Tech (NASDAQ: HIT) has reported a substantial financial performance for the third quarter of 2025, marking a 90% year-over-year revenue growth to $8.5 million. For the nine-month period, total revenue reached $25.8 million, which is already 132% of the full-year revenue for 2024. The company has launched new underwriting solutions aimed at streamlining the quoting process for large employers, enhancing operational efficiency. Additionally, a non-binding Letter of Intent with AlphaTON Capital will explore blockchain technology solutions for claims administration, indicating a progressive step towards modernizing healthcare processes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenue increased by 90% year over year, reaching $8.5 million.
  • Strategic partnerships, such as with AlphaTON Capital, aim to modernize healthcare claims administration.
  • Health In Tech has achieved 132% of its full-year 2024 revenue in just nine months.

Full Press Release Details

In Tech Announces Third Quarter 2025 Financial Results
FL., Nov 10, 2025 /PRNewswire/ - Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology,
today announced its financial results for the third quarter ended September 30, 2025.
Highlights for the Third Quarter and Nine-Month of 2025:
Johnson, CEO of Health In Tech, said:
third quarter highlights the accelerating strength of our distribution ecosystem and the solid foundation we've built this year.
Revenue reached $8.5 million, up 90% year over year, bringing nine-month revenue to $25.8 million-already 132% of full-year 2024
revenue. This growth reflects the continued expansion of our broker, TPA, and agency network, which is now translating directly into
sustained revenue momentum as our technology gains adoption across new distribution channels."
September, we launched large-employer underwriting within eDIYBS, allowing brokers to generate quotes for groups of 150 or more employees
in as little as two weeks-versus the industry timeline of often three months. This capability is a significant milestone, extending
the speed and scalability of our small-business underwriting into the mid- and large-employer market. It marks a major step forward in
how health plans are designed, quoted, and delivered at scale."
also remain focused on solving one of the most costly inefficiencies in U.S. healthcare-claims administration, which costs the
industry more than $300 billion annually. Our non-binding LOI with AlphaTON Capital marks a strategic step toward exploring blockchain-enabled
solutions that can modernize this process. Together with AlphaTON and Brittany Kaiser's leadership in blockchain ethics and policy,
we're developing HITChain-a decentralized, verifiable claims infrastructure designed to compress processing timelines, eliminate
duplication, lower costs, and create a transparent system of record for all stakeholders.
combining insurance domain expertise with blockchain innovation, we're seeking to position Health In Tech at the frontier of decentralized
healthcare infrastructure-a market opportunity of substantial scale and long-term impact."
delivered another quarter of strong financial performance," said Julia Qian, CFO of Health In Tech. "Revenue grew 90% year
over year and profit increased 48%, reflecting both operational strength and disciplined execution. We continue to balance growth with
strategic investments in technology and enhanced platform capabilities-initiatives that reinforce our leadership position and support
sustainable long-term performance."
Business Developments and Highlights
In Tech will host a conference call to discuss the financial results for the Third quarter of 2025 on Nov 10, 2025, at 5:00 p.m. (ET).
To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).
live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/.
A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and
will remain available for approximately 90 days.
Financial Information
release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance
with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of historical non-GAAP
financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end
of Forward-Looking Statements
statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities
Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed
operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment,
and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will,"
"should," "design," "target," "aim," "hope," "expect," "could,"
"intend," "plan," "anticipate," "estimate," "believe," "continue," "predict,"
"project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes.
These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties
and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from
any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should
not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors
which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity,
performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and
is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth
strategy and liquidity.
In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace
that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing
friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs.
Learn more at healthintech.com.
Statements of Operations
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
Revenues
Revenues from underwriting modeling (ICE) $ 1,389,604 $ 1,528,451 $ 5,832,164 $ 4,952,191
Revenues from fees 7,100,489 2,930,470 19,986,762 9,634,151
SMR 7,100,489 2,250,549 19,986,762 7,379,016
HI Card - 679,921 - 2,255,135
Total revenues 8,490,093 4,458,921 25,818,926 14,586,342
Cost of revenues 3,346,277 979,628 9,009,841 2,944,266
Gross profit 5,143,816 3,479,293 16,809,085 11,642,076
Operating expenses
Sales and marketing expenses 962,567 508,467 3,279,560 2,526,197
General and administrative expenses 3,451,907 1,813,520 10,474,125 5,629,393
Research and development expenses 235,819 718,424 1,356,149 2,180,246
Total operating expenses 4,650,293 3,040,411 15,109,834 10,335,836
Other income (expense):
Interest income 111,699 38,460 305,263 94,111
Interest expenses - (165,000 ) - (495,000 )
Other income - 157,156 118,399 157,156
Other expense (5,000 ) (62,759 ) (5,000 ) (62,759 )
Total other income (expense), net 106,699 (32,143 ) 418,662 (306,492 )
Income before income tax expense $ 600,222 $ 406,739 $ 2,117,913 $ 999,748
Provision for income taxes (148,046 ) (30,653 ) (536,514 ) (185,119 )
Net income $ 452,176 $ 376,086 $ 1,581,399 $ 814,629
Net income per share
Basic $ 0.01 $ 0.01 $ 0.03 $ 0.02
Diluted $ 0.01 $ 0.01 $ 0.03 $ 0.02
Weighted average common stocks outstanding
Basic 56,432,407 51,769,358 55,484,860 51,769,358
Diluted 58,774,334 51,769,358 57,477,873 51,769,358
September 30, 2025 December 31, 2024
Assets
Current assets
Cash $ 8,023,613 $ 7,849,248
Accounts receivable, net 868,628 1,647,103
Other receivables 3,871,106 500,252
Deferred offering costs 166,012 -
Prepaid expenses and other current assets 2,117,854 787,161
Total current assets 15,047,213 10,783,764
Non-current assets
Software 6,182,691 3,962,461
Loans receivable, net 863,996 815,995
Operating lease - right of use assets 157,122 206,269
Long-term prepaid expenses 504,822 -
Total non-current assets 7,708,631 4,984,725
Total assets $ 22,755,844 $ 15,768,489
Liabilities and stockholders' equity
Current liabilities
Accounts payable and accrued expenses $ 4,295,384 $ 1,858,840
Income taxes payable - 205,253
Operating lease liabilities - current 73,769 66,881
Other current liabilities 869,088 -
Total current liabilities 5,238,241 2,130,974
Non-current liabilities
Deferred tax liabilities 274,809 328,676
Operating lease liabilities - non-current 83,831 139,811
Total non-current liabilities 358,640 468,487
Total liabilities 5,596,881 2,599,461
Stockholders' equity
Common stock, $0.001 par value; Class A Common stock 150,000,000 shares authorized, 44,785,771 and 42,914,870 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 44,785 42,915
Common stock, $0.001 par value; Class B Common stock 50,000,000 shares authorized, 11,700,000 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 11,700 11,700
Additional paid-in capital 11,579,683 9,173,017
Retained earnings 5,522,795 3,941,396
Total stockholders' equity 17,158,963 13,169,028
Total liabilities and stockholders' equity $ 22,755,844 $ 15,768,489
Statements of Cash Flows
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 452,176 $ 376,086 $ 1,581,399 $ 814,629
Adjustments to reconcile net income to net cash provided by operating activities:
Write-off of accounts receivable (4,089 ) - 1,901 -
Amortization expense 217,981 135,584 489,947 405,158
Provision for refund liability 1,413,345 - 2,369,088 -
Deferred tax expenses (benefits) 12,680 (27,676 ) (53,867 ) (86,992 )
Amortization of debt discount - 165,000 - 495,000
Interest income (16,003 ) (15,999 ) (48,001 ) (47,997 )
Stock-based compensation expense 292,552 - 1,493,686 -
Changes in operating assets and liabilities:
Accounts receivable, net 416,592 524,838 776,574 1,302,733
Other receivables (16,272 ) 546,645 (3,370,854 ) 1,166,017
Prepaid expenses and other current assets (486,424 ) (118,116 ) (690,665 ) (209,841 )
Long-term prepaid expenses 151,000 - (206,666 ) -
Operating lease right of use assets and liabilities, net 18 624 55 1,871
Accounts payable and accrued expenses (224,639 ) 491,031 2,045,258 (1,064,527 )
Income taxes payable (34,944 ) 43,030 (205,253 ) (68,675 )
Other current liabilities (1,500,000 ) - (1,500,000 ) -
Net cash provided by operating activities 673,973 2,121,047 2,682,602 2,707,376
CASH FLOWS FROM INVESTING ACTIVITIES:
Development of software (744,841 ) (67,278 ) (2,358,213 ) (294,634 )
Net cash used in investing activities (744,841 ) (67,278 ) (2,358,213 ) (294,634 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of deferred offering costs (43,685 ) (324,744 ) (150,024 ) (936,864 )
Repayments of notes payable - (2,145,000 ) - (2,145,000 )
Net cash used in financing activities (43,685 ) (2,469,744 ) (150,024 ) (3,081,864 )
Increase (decrease) in cash (114,553 ) (415,975 ) 174,365 (669,122 )
Cash, beginning of the period 8,138,166 2,163,203 7,849,248 2,416,350
Cash, end of the period 8,023,613 1,747,228 8,023,613 1,747,228
Supplemental disclosures of cash flow information:
Cash paid for interest $ - $ - $ - $ -
Cash paid for income taxes $ 198,000 $ 15,300 $ 823,323 $ 340,787
Summary of noncash investing and financing activities:
Accrued deferred offering costs included in accounts payable and accrued expenses $ 55,827 $ 137,325 $ 55,827 $ 137,325
Accrued development of software included in accounts payable and accrued expenses $ 401,964 $ 126,977 $ 401,964 $ 126,977
Issuance of Class A common stock for future service $ 146,816 $ - $ 1,184,800 $ -
EBITDA Reconciliation
For Three Months Ended September 30, For Nine Months Ended September 30,
2025 2024 2025 2024
Net income $ 452,176 $ 376,086 $ 1,581,399 $ 814,629
Interest (income) expenses (111,699 ) 126,540 (305,263 ) 400,889
Depreciation and amortization 217,981 135,584 489,947 405,158
Income tax expense 148,046 30,653 536,514 185,119
Stock-based compensation expense 292,552 - 1,493,686 -
Total net adjustments 546,880 292,777 2,214,884 991,166
Adjusted EBITDA $ 999,056 $ 668,863 $ 3,796,283 $ 1,805,795
of Operating Results
we generate our revenue primarily from small employers and insurance carriers, we grow our business primarily from offering solutions
that streamline sales processes, enhance service delivery, and reduce the sales cycle duration for TPAs, MGUs, and Brokers. We offer
our services through our three subsidiaries. Program services provided by SMR and MGU activities provided by ICE (including eDIYBS) are
interdependent, as they cannot function effectively without being combined. Services provided by HI Card are an optional add-on to our
other services, and cannot be offered on a standalone basis. Brokers that utilize the program services on behalf of the small employer
provided by SMR and MGU activities provided by ICE, are not obligated to utilize our HI Card service. Currently ICE does not offer underwriting
services as a standalone service. In the future, we may consider offering it as a standalone service.
of revenues primarily consists of infrastructure costs to operate our platform such as hosting fees and fees paid to various third-party
partners for access to their technology, services and amortization expenses of our capitalized internal-use software related to our platform.
We mainly outsource captive management services and data services from the third-party companies. Our internal proprietary system seeks
to consistently improve underwriting and services results through machine learning and data feeds. The captive management activities
include introducing new carriers, conducting due diligence on carriers, conducting feasibility studies to determine the viability to
be a stop-loss carrier on the platform, negotiating terms and contracts, coordinating audit requests, managing relationship with unrelated
carriers and their regulators and auditor firms to ensure that our risk associated with our service offerings is minimized.
and marketing expenses
and marketing expenses primarily consist of personnel-related costs including salaries, stock-based compensation expense, benefits and
commissions cost for our sales and marketing personnel. Sales and marketing expenses also include the costs for advertising, promotional
and other marketing activities, as well as certain fees paid to various third-party for sales and customer acquisition.
and administrative expenses
and administrative expenses primarily consist of personnel-related costs and related expenses for our executives, finance, legal, human
resources, technical support, and administrative personnel as well as the costs associated with professional fees for external legal,
accounting and other consulting services, insurance premiums.
and development expenses
and development expenses primarily consist of personnel-related costs, including salaries, stock-based compensation expense and benefits
for our research and development personnel. Additional expenses include costs related to the software development, quality assurance,
and testing of new technology, and enhancement of our existing platform technology.
EBITDA represents our net income before net interest expense, taxes, and depreciation and amortization expense, adjusted to eliminate
stock-based compensation expense. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting
Principles, or GAAP. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA, and we believe this approach
provides a more meaningful measure by offering a clearer view of our underlying operational performance.
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 % Change 2025 2024 % Change
Total revenues $ 8.5 $ 4.5 90.4 % $ 25.8 $ 14.6 77.0 %
GAAP gross margin 60.6 % 78.0 % -17.4 % $ 65.1 % $ 79.8 % -14.7 %
Income before income tax expense $ 0.6 $ 0.4 47.6 % $ 2.1 $ 1.0 111.8 %
Adjusted EBITDA $ 1.0 $ 0.7 49.4 % $ 3.8 $ 1.8 110.2 %

Frequently Asked Questions

What were Health In Tech's revenues for Q3 2025?

Health In Tech generated $8.5 million in revenue for Q3 2025.

How much did Health In Tech's revenue grow year-over-year?

The revenue grew by 90% compared to the previous year.

When will Health In Tech discuss their financial results?

They will hold a conference call on November 10, 2025, at 5:00 p.m. ET.

What milestone was reached with the eDIYBS launch?

eDIYBS allows brokers to quote large groups in approximately two weeks.

What strategic partnership has Health In Tech announced?

They have a non-binding LOI with AlphaTON Capital to explore blockchain solutions.

Last updated: Nov 10, 2025